Whitehawk Therapeutics, Inc. · NASDAQ:WHWK
Lennon David James sold 26,858 Whitehawk Therapeutics, Inc. shares (Form 4)
Traded Apr 1 to Apr 2, 2026 · Filed Apr 3, 2026
From Apr 1 to Apr 2, 2026, Lennon David James (Director, CHIEF EXECUTIVE OFFICER) sold 26,858 Whitehawk Therapeutics, Inc. shares at US$3.48 for US$93,466, leaving 793,549 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 26,858 shares
- Price
- US$3.48
- Value
- US$93,466
- Holding after
- 793,549 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 775,828 | 820,407 | Direct | |
| Apr 2, 2026 | Common Stock | Sale | 26,858 | US$3.48 | 793,549 | Direct |
Source
Related
- Whitehawk Therapeutics, Inc.
- Lennon David James
- Whitehawk Therapeutics, Inc. shareholders
- Form 4 · Lennon David James · May 18, 2026
- Form 4 · Lennon David James · Apr 10, 2026
- Form 4 · Lennon David James · Apr 8, 2026
- Schedule 13G/A · Fan Yu · Aug 14, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Form 4 · Dalal Anupam · Jul 30, 2026
- Form 4 · Dugan Margaret · May 18, 2026
- Form 4 · Ball Bryan · May 18, 2026